🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
A growing number of patients with Crohn's disease are treated with immunosu...
Status
Completed
Location
Yonsei University: Wonju Christian Hospital
Start Date
2011-12
Trial ID
NCT01505855
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00452790
Treatments Being Tested
phase-1 study pneumococcal conjugate vaccine study in healthy adults...
Status
Unknown
Location
Multiple Locations
Start Date
2018-07-01
Trial ID
NCT03549208
Advisory Committee for Immunization Practices (ACIP) from the Centers for D...
Status
Completed
Location
Mayo Clinic
Start Date
2016-04
Trial ID
NCT02719379
Treatments Being Tested
The objective of the study is to evaluate the safety, tolerability, and imm...
Status
Active Not Recruiting
Location
The Children's Clinic of Jonesboro, P.A
Start Date
2024-11-25
Trial ID
NCT06720038
This randomized clinical trial (RCT) evaluates whether metformin can reduce...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-04-07
Trial ID
NCT06829238
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study will evaluate the immunogenicity of a reduced dosing schedule of...
Status
Completed
Location
Chris Hani Baragwanath Academic Hospital
Start Date
2017-01-09
Trial ID
NCT02943902
Treatments Being Tested